Ekström G, Di Monte D, Sandy M S, Smith M T
Arch Biochem Biophys. 1987 May 15;255(1):14-8. doi: 10.1016/0003-9861(87)90289-x.
MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is converted by monoamine oxidase B to its putative toxic metabolite MPP+ (1-methyl-4-phenylpyridinium ion) via MPDP+ (1-methyl-4-phenyl-2,3-dihydropyridinium ion). Both the parent compound and these two major metabolites were toxic to isolated rat hepatocytes with MPDP+ being the most toxic and MPP+ the least effective. MPP+ produced a slight increase in lipid peroxidation above control levels in hepatocytes, while both MPTP and MPDP+ showed antioxidant effects. The latter two compounds also protected against chemically and nonchemically induced lipid peroxidation in rat liver microsomes. MPDP+ was effective at much lower concentrations than MPTP. MPDP+ was also markedly more efficient when NADPH was used to induce microsomal lipid peroxidation. Lipid peroxidation as a consequence of oxygen radical generation is therefore unlikely to be involved in MPTP toxicity in vitro and the rationale of using chain-breaking antioxidants as protective agents in vivo needs a more careful evaluation.
1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)经单胺氧化酶B作用,通过1-甲基-4-苯基-2,3-二氢吡啶离子(MPDP +)转化为其假定的有毒代谢物1-甲基-4-苯基吡啶离子(MPP +)。母体化合物以及这两种主要代谢物对分离的大鼠肝细胞均有毒性,其中MPDP +毒性最强,MPP +毒性最弱。MPP +使肝细胞中的脂质过氧化水平比对照水平略有升高,而MPTP和MPDP +均表现出抗氧化作用。后两种化合物还能保护大鼠肝微粒体免受化学和非化学诱导的脂质过氧化。MPDP +在比MPTP低得多的浓度下就有效。当使用烟酰胺腺嘌呤二核苷酸磷酸(NADPH)诱导微粒体脂质过氧化时,MPDP +的效率也明显更高。因此,由氧自由基产生导致的脂质过氧化不太可能参与MPTP的体外毒性作用,在体内使用链断裂抗氧化剂作为保护剂的基本原理需要更仔细地评估。